In this episode of The BioHub Podcast, Ben is joined by Craig Thompson, CEO of Cerevance.

Craig has spent over three decades across biotech and pharma, leading companies through major stages of growth, development and strategic transformation. Today, he leads Cerevance, a clinical-stage neuroscience company focused on developing new medicines for neurological and neuropsychiatric diseases.

In this conversation, Ben and Craig discuss Cerevance’s work in Parkinson’s disease, the challenges of late-stage CNS development, what it takes to build conviction in neurodegeneration, and how companies think about execution, leadership and potential commercialization in one of the most complex areas of medicine.

They also explore Craig’s journey through the industry, the lessons he has carried across leadership roles, and why patient impact remains central to building a successful biotech company.